NCT03012009View on ClinicalTrials.gov

Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Bowen's DiseaseSuperficial Basal Cell Carcinoma
Interventions
DEVICE

full ablative CO2 laser

ablation to the level of de dermal papilla

DEVICE

fractional ablative CO2 laser

180 micron HP, pulse 8ms, 15% overlay, 30 W (943J/cm)

DRUG

MAL

DEVICE

LED lamp

peak wavelength 630 nm, 37J/cm2

DRUG

lidocaine hydrochloride 2% with epinephrine

Trial Locations (1)

Unknown

Department of Dermatology, Ghent University Hospital, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT03012009 - Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial | Biotech Hunter | Biotech Hunter